Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7304 p766-768
19 June 2004

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Letters

· The Society
· The Council
· Free movement in Europe
· Mystery shopping
· The profession


Letters to the Editor

The Council

Charter links

Can we have a little vision, please?

Is the Council truly representative of the membership?

Failure will see the destruction, not the saving, of our Society

Can we have a little vision, please?

From Mr A. R. White, MRPharmS

I am still trying to find out how the previous Council got our Royal Pharmaceutical Society into the current position. I previously noted a suggestion by David Sharpe, speaking at the annual general meeting, that senior members of the Society’s staff might have been working to a “hidden agenda” (PJ, 22 May, p653) and I had been intending to ask for more information on this. However, I believe that I may have found the source of many, if not all, of our problems.

It seems that I should look no further than Jim Smith, the senior pharmacist working for the Government (PJ, 12 June, p727). At the Society’s AGM, he was quoted as saying that the Government wants “a meld of the Society serving the public interest and persisting in its role ... as an effective professional body” (PJ, 22 May, p653).

Yet he now says that (in his opinion) what seems to be the only practical way of achieving this is not a “satisfactory proposal”. At present the Society is an exception and, alone among all the UK health-related professional bodies, has both regulatory and professional representative functions. Surely someone in Government has enough vision to see that, in order to continue with these duties, we need to continue to be (at least a little bit) exceptional. I sincerely hope that those in the DoH working on this matter will feel able to recognise that our new Council has been given a mandate to achieve precisely what we are told the Government wants and will work with the Society to this end.

Renewed reference (in recent letters) to the need for the Society to act for the public benefit has spurred me to look at the websites for the General Medical Council and the British Medical Association.

One is a charity, has legal powers under the Medical Act to act to protect patients, is governed by a body with a small majority (54 per cent) of doctors and has some responsibility for education and training. The other has a scientific and educational function, is a publishing house and represents and protects doctors’ professional interests. Which one do you think is an almost precise equivalent of the Society that was to be enshrined in the proposed new Charter?

Finally, I do not pretend to be a legal expert but I did find Mr Justice Park’s ruling unsatisfactory. It appears from Graeme Smith’s concise article (PJ, 29 May, p665) that the judge did not consider the terms of the existing Charter. He says he had “no view about the merits” of the new Charter and so, presumably, did not consider any need to judge whether a proposal to “run” the Society in a new way was in contravention of our existing one. That, as I understand it, is what the Save Our Society campaign wanted to be considered. Perhaps the judge thought this a matter of ethics and not of law. Hopefully, if there is an appeal, we shall know.

Alan White
Gravesend, Kent


Is the Council truly representative of the membership?

From Mr R. G. Medlow, MRPharmS

I agree with James Mearns (PJ, 12 June, p738) in his explanation of how an organised group of candidates was able to capture all seven places in the Royal Pharmaceutical Society’s Council election.

Two years or so back, the Council decided that we should revert to the winner-takes-all X-voting system, thereby abandoning the single transferable vote, introduced into the Society’s Council elections some 30 years ago, which provides fair representation of all significant interest groups.

If the Save Our Society group organises itself in a similar way next year and the year after, they will capture all the elected places on Council. Do not say the membership would not allow this — it could happen all too easily.

I have no particular position on the proposed new Charter. My personal interest is that the outcome of an election should, as far as possible, reflect the views of all the voters and not totally exclude a substantial minority.

We should, next year, return to preferential voting as used by almost all other health care professionals. But will a Council elected by the winner-takes-all system vote for a return to a democratic representative voting system?

Ron Medlow
Guildford, Surrey


Failure will see the destruction, not the saving, of our Society

From Mr D. A. Hancox, MRPharmS

I am becoming increasingly pessimistic as far as the Royal Pharmaceutical Society is concerned.

The continuing low number of members voting in Council elections, the formation and actions of the Save Our Society group and the failure to give an able president a second term of office (together with the vice-president and treasurer) all combine to give me serious concerns for the future.

Although I have been disappointed by, and disagreed with, some decisions made by the Council at various times I fully accept that my views are simply my views and I have not been fully aware of the background and the constraints within which the Council has had to act. Overall I believe successive Councils have given leadership, policies and support to the profession that has enabled it to go continually forward. That view extends to the recent Council in respect of the modernisation issue and the Charter.

All Councils have a grave responsibility to enact sound policy and none more so than the newly elected Council. Failure to secure a Society that embraces both a regulatory and a representative role and that maintains a membership across all areas of pharmacy practice will see the destruction, not the saving, of our Society.

Douglas Hancox
Auckland, New Zealand

Send your letter to The Editor

Previous Topic (The Society)
Next Topic (Free movement in Europe)

Back to Top


©The Pharmaceutical Journal